TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Earnings Estimates
USA - New York Stock Exchange - NYSE:TEVA - US8816242098 - ADR
31.81 USD
+0.15 (+0.47%)
31.6251 USD
-0.18 (-0.58%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.925B -6.00% | 15.846B 6.17% | 16.544B 4.40% | 17.308B 4.62% | 17.366B 0.34% | 17.656B 1.67% | |
| EBITDA YoY % growth | 4.493B -5.37% | 4.693B 4.45% | 4.647B -0.98% | 5.025B 8.13% | 5.268B 4.84% | 5.674B 7.71% | |
| EBIT YoY % growth | 3.185B -6.82% | 3.54B 11.15% | 3.588B 1.36% | 4.433B 23.55% | 4.536B 2.32% | 4.952B 9.17% | |
| Operating Margin | 21.34% | 22.34% | 21.69% | 25.61% | 26.12% | 28.05% | |
| EPS YoY % growth | 2.57 -1.94% | 2.60 1.19% | 2.53 -2.73% | 2.73 8.14% | 2.83 3.48% | 3.18 12.64% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.70 -2.41% | 0.59 11.02% | 0.65 -2.64% | 0.77 -3.23% | 0.78 10.40% |
| Revenue Q2Q % growth | 4.455B 5.34% | 4.086B 5.01% | 4.273B 2.32% | 4.505B 0.56% | 4.46B 0.11% |
| EBITDA Q2Q % growth | 1.318B -34.88% | 1.185B 15.16% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.182B 22.49% | 1.028B 30.96% | 1.115B 17.62% | 1.258B 12.32% | 1.276B 7.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.79 13.04% | 0.68 | 0.11 | 16.51% |
| Q2 2025 Q2Q % growth | 0.67 8.20% | 0.64 | 0.03 | 4.65% |
| Q1 2025 Q2Q % growth | 0.53 8.33% | 0.50 | 0.03 | 5.84% |
| Q4 2024 Q2Q % growth | 0.72 -29.00% | 0.71 | 0.01 | 2.01% |
| Q3 2024 Q2Q % growth | 0.70 15.00% | 0.68 | 0.02 | 3.02% |
| Q2 2024 Q2Q % growth | 0.62 8.93% | 0.59 | 0.03 | 4.92% |
| Q1 2024 Q2Q % growth | 0.49 20.00% | 0.54 | -0.05 | -8.98% |
| Q4 2023 Q2Q % growth | 1.01 40.85% | 0.79 | 0.22 | 28.49% |
| Q3 2023 Q2Q % growth | 0.61 1.69% | 0.62 | -0.01 | -1.59% |
| Q2 2023 Q2Q % growth | 0.57 -17.65% | 0.55 | 0.02 | 3.64% |
| Q1 2023 Q2Q % growth | 0.41 -27.27% | 0.58 | -0.18 | -30.51% |
| Q4 2022 Q2Q % growth | 0.72 -7.79% | 0.79 | -0.07 | -8.41% |
| Q3 2022 Q2Q % growth | 0.60 | 0.65 | -0.05 | -7.45% |
| Q2 2022 Q2Q % growth | 0.69 15.25% | 0.62 | 0.07 | 11.11% |
| Q1 2022 Q2Q % growth | 0.56 -12.70% | 0.63 | -0.07 | -11.60% |
| Q4 2021 Q2Q % growth | 0.78 13.24% | 0.75 | 0.04 | 4.85% |
| Q3 2021 Q2Q % growth | 0.60 1.72% | 0.66 | -0.06 | -9.62% |
| Q2 2021 Q2Q % growth | 0.60 7.27% | 0.65 | -0.05 | -8.19% |
| Q1 2021 Q2Q % growth | 0.64 | 0.63 | 0.01 | 1.25% |
| Q4 2020 Q2Q % growth | 0.69 | 0.65 | 0.04 | 5.82% |
| Q3 2020 Q2Q % growth | 0.59 | 0.61 | -0.02 | -3.62% |
| Q2 2020 Q2Q % growth | 0.56 | 0.62 | -0.06 | -10.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 4.48B 3.42% | 4.44B | 40M | 0.90% |
| Q2 2025 Q2Q % growth | 4.176B 0.29% | 4.385B | -209M | -4.77% |
| Q1 2025 Q2Q % growth | 3.891B 1.89% | 4.082B | -191M | -4.68% |
| Q4 2024 Q2Q % growth | 4.229B -5.12% | 4.203B | 26M | 0.62% |
| Q3 2024 Q2Q % growth | 4.332B 12.52% | 4.221B | 111M | 2.63% |
| Q2 2024 Q2Q % growth | 4.164B 7.49% | 4.13B | 34M | 0.82% |
| Q1 2024 Q2Q % growth | 3.819B 4.15% | 3.834B | -15M | -0.39% |
| Q4 2023 Q2Q % growth | 4.457B 14.75% | 4.074B | 383M | 9.40% |
| Q3 2023 Q2Q % growth | 3.85B 7.09% | 3.794B | 56M | 1.48% |
| Q2 2023 Q2Q % growth | 3.874B 2.32% | 3.764B | 110M | 2.92% |
| Q1 2023 Q2Q % growth | 3.667B 0.16% | 3.717B | -50M | -1.35% |
| Q4 2022 Q2Q % growth | 3.884B -5.27% | 3.98B | -96M | -2.41% |
| Q3 2022 Q2Q % growth | 3.595B -7.51% | 3.948B | -353M | -8.94% |
| Q2 2022 Q2Q % growth | 3.786B -3.17% | 3.93B | -144M | -3.66% |
| Q1 2022 Q2Q % growth | 3.661B -8.06% | 3.966B | -305M | -7.69% |
| Q4 2021 Q2Q % growth | 4.1B -7.93% | 4.388B | -288M | -6.56% |
| Q3 2021 Q2Q % growth | 3.887B -2.29% | 4.077B | -190M | -4.66% |
| Q2 2021 Q2Q % growth | 3.91B 1.03% | 4.168B | -258M | -6.19% |
| Q1 2021 Q2Q % growth | 3.982B -8.61% | 4.144B | -162M | -3.91% |
| Q4 2020 Q2Q % growth | 4.453B | 4.428B | 25M | 0.56% |
| Q3 2020 Q2Q % growth | 3.978B | 4.129B | -151M | -3.66% |
| Q2 2020 Q2Q % growth | 3.87B | 4.194B | -324M | -7.73% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.4% | -5.97% | -0.37% | 2.79% |
| Revenue | -0.87% | -1.83% | 0% | 0.24% |